GALAPAGOS NV (GLPG.AS) Stock Fundamental Analysis

AMS:GLPG • BE0003818359

28.7 EUR
-0.16 (-0.55%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Overall GLPG gets a fundamental rating of 2 out of 10. We evaluated GLPG against 78 industry peers in the Biotechnology industry. GLPG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GLPG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • GLPG had negative earnings in the past year.
  • In the past year GLPG has reported a negative cash flow from operations.
  • In multiple years GLPG reported negative net income over the last 5 years.
  • In the past 5 years GLPG always reported negative operating cash flow.
GLPG.AS Yearly Net Income VS EBIT VS OCF VS FCFGLPG.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

  • The Return On Assets of GLPG (-12.42%) is better than 64.10% of its industry peers.
  • GLPG has a Return On Equity of -17.83%. This is in the better half of the industry: GLPG outperforms 69.23% of its industry peers.
Industry RankSector Rank
ROA -12.42%
ROE -17.83%
ROIC N/A
ROA(3y)0.68%
ROA(5y)-1.06%
ROE(3y)0.5%
ROE(5y)-2.77%
ROIC(3y)N/A
ROIC(5y)N/A
GLPG.AS Yearly ROA, ROE, ROICGLPG.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

  • In the last couple of years the Profit Margin of GLPG has grown nicely.
  • GLPG has a Gross Margin of 84.31%. This is in the better half of the industry: GLPG outperforms 74.36% of its industry peers.
  • In the last couple of years the Gross Margin of GLPG has declined.
  • GLPG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y9.7%
GM growth 3Y-4.31%
GM growth 5YN/A
GLPG.AS Yearly Profit, Operating, Gross MarginsGLPG.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • GLPG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, GLPG has about the same amount of shares outstanding.
  • GLPG has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, GLPG has a worse debt to assets ratio.
GLPG.AS Yearly Shares OutstandingGLPG.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GLPG.AS Yearly Total Debt VS Total AssetsGLPG.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.57, we must say that GLPG is in the distress zone and has some risk of bankruptcy.
  • GLPG has a better Altman-Z score (1.57) than 66.67% of its industry peers.
  • GLPG has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of GLPG (0.00) is better than 91.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.57
ROIC/WACCN/A
WACC7.94%
GLPG.AS Yearly LT Debt VS Equity VS FCFGLPG.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • A Current Ratio of 8.63 indicates that GLPG has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 8.63, GLPG belongs to the top of the industry, outperforming 91.03% of the companies in the same industry.
  • A Quick Ratio of 8.56 indicates that GLPG has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 8.56, GLPG belongs to the top of the industry, outperforming 91.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.63
Quick Ratio 8.56
GLPG.AS Yearly Current Assets VS Current LiabilitesGLPG.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • GLPG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -311.50%.
  • Measured over the past years, GLPG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.47% on average per year.
  • Looking at the last year, GLPG shows a very negative growth in Revenue. The Revenue has decreased by -43.05% in the last year.
  • The Revenue for GLPG have been decreasing by -20.82% on average. This is quite bad
EPS 1Y (TTM)-311.5%
EPS 3YN/A
EPS 5Y-12.47%
EPS Q2Q%-298.7%
Revenue 1Y (TTM)-43.05%
Revenue growth 3Y-20.01%
Revenue growth 5Y-20.82%
Sales Q2Q%18.9%

3.2 Future

  • GLPG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -40.64% yearly.
  • Based on estimates for the next years, GLPG will show a decrease in Revenue. The Revenue will decrease by -8.87% on average per year.
EPS Next Y-541.12%
EPS Next 2Y-89.82%
EPS Next 3Y-64.76%
EPS Next 5Y-40.64%
Revenue Next Year-5.4%
Revenue Next 2Y-2.5%
Revenue Next 3Y-3.52%
Revenue Next 5Y-8.87%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GLPG.AS Yearly Revenue VS EstimatesGLPG.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
GLPG.AS Yearly EPS VS EstimatesGLPG.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • GLPG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GLPG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GLPG.AS Price Earnings VS Forward Price EarningsGLPG.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GLPG.AS Per share dataGLPG.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as GLPG's earnings are expected to decrease with -64.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-89.82%
EPS Next 3Y-64.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • GLPG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GALAPAGOS NV

AMS:GLPG (2/20/2026, 7:00:00 PM)

28.7

-0.16 (-0.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05
Earnings (Next)02-24
Inst Owners24.93%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.89B
Revenue(TTM)286.92M
Net Income(TTM)-436.26M
Analysts51.58
Price Target31.14 (8.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10823.9%
Min EPS beat(2)-19965.4%
Max EPS beat(2)-1682.53%
EPS beat(4)1
Avg EPS beat(4)-5642.06%
Min EPS beat(4)-19965.4%
Max EPS beat(4)154.1%
EPS beat(8)4
Avg EPS beat(8)-2655.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.56%
Min Revenue beat(2)-10.27%
Max Revenue beat(2)-2.86%
Revenue beat(4)1
Avg Revenue beat(4)-5.15%
Min Revenue beat(4)-11.82%
Max Revenue beat(4)4.35%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.3%
PT rev (3m)5.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)55.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-79.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.59
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)-6.62
EYN/A
EPS(NY)-1.8
Fwd EYN/A
FCF(TTM)-4.36
FCFYN/A
OCF(TTM)-4.08
OCFYN/A
SpS4.35
BVpS37.13
TBVpS37.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.42%
ROE -17.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.31%
FCFM N/A
ROA(3y)0.68%
ROA(5y)-1.06%
ROE(3y)0.5%
ROE(5y)-2.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y9.7%
GM growth 3Y-4.31%
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.12%
Cap/Sales 6.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.63
Quick Ratio 8.56
Altman-Z 1.57
F-Score2
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)93.66%
Cap/Depr(5y)187.37%
Cap/Sales(3y)17.05%
Cap/Sales(5y)15.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-311.5%
EPS 3YN/A
EPS 5Y-12.47%
EPS Q2Q%-298.7%
EPS Next Y-541.12%
EPS Next 2Y-89.82%
EPS Next 3Y-64.76%
EPS Next 5Y-40.64%
Revenue 1Y (TTM)-43.05%
Revenue growth 3Y-20.01%
Revenue growth 5Y-20.82%
Sales Q2Q%18.9%
Revenue Next Year-5.4%
Revenue Next 2Y-2.5%
Revenue Next 3Y-3.52%
Revenue Next 5Y-8.87%
EBIT growth 1Y-67.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-68.33%
EBIT Next 3Y-7.6%
EBIT Next 5Y22.11%
FCF growth 1Y46.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.17%
OCF growth 3YN/A
OCF growth 5YN/A

GALAPAGOS NV / GLPG.AS FAQ

What is the fundamental rating for GLPG stock?

ChartMill assigns a fundamental rating of 2 / 10 to GLPG.AS.


Can you provide the valuation status for GALAPAGOS NV?

ChartMill assigns a valuation rating of 0 / 10 to GALAPAGOS NV (GLPG.AS). This can be considered as Overvalued.


What is the profitability of GLPG stock?

GALAPAGOS NV (GLPG.AS) has a profitability rating of 2 / 10.